Inviting Expression of Interest from Industry to license/partner/co-develop/commercialise a Computational pipeline for analysis and clinical interpretation of Myeloid Cancer panel data. For more info, see https://is.gd/myeloid Contact person: Mr Pankaj Bansal, Head, Business Development CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) email : pbansal@igib.res.in ADVANTAGES 1. Easy to use web-based interface which can be used online/offline or on the cloud 2. Standard data analysis and interpretation interface with automation of all aspects from alignment, variant calling and clinical reporting (FASTQ to Report). 3. High quality data curation by expert clinicians with tagging of clinically relevant and actionable mutations and Pharmacogenetic variants. 4. Customizable database to include lab-specific /custom data of relevance. 5. Compatible with major next-generation sequencing based gene panels for Myeloid neoplasms 6. Enables identification and characterization of clinically relevant Internal Tandem Duplications (ITD)s 7. Standardized interface and reporting including option to export in standard PDF formats. |  |
|
|
Partners
| About OPTIMA Concept and Background Vinod Scaria Lab Sridhar Sivasubbu Lab |
Partnering with OPTIMA OPTIMA Partner Network Hospitals and Medical Centres Non Governmental Organisations Technologies and Knowhow for Commercialisation |
Publications & Presentations Peer Reviewed Publications Presentations Whitepapers Upcoming Events Genomics for Clinicians |
Social Media
  GUaRDIAN programme for Rare Genetic Diseases GOMED initiative at CSIR-IGIB |